Looks like you are not TradeKey.com's Member yet. Signup now to connect with over 11 Million Importers & Exporters globally. Join Now |
BOOK A CALL
Book Call On Your Favorite Time
Code
🗘

By Signing Up. I agree to TradeKey.com Terms of Use, Privacy Policy, IPR and receive emails related to our services

Contact Us
product
Prev
Tofacitinib Citrate Tofacitinib Citrate Tofacitinib Citrate Tofacitinib Citrate
Next

Tofacitinib Citrate

FOB Price

Get Latest Price

2.89 ~ 3.89 USD /

|

100 Gram Minimum Order

Country:

China

Model No:

-

FOB Price:

2.89 ~ 3.89 USD / Get Latest Price

Place of Origin:

-

Price for Minimum Order:

2.89

Minimum Order Quantity:

100 Gram

Packaging Detail:

Aluminum Foil Bags or Fiber Drum

Delivery Time:

Within 7-12 days

Supplying Ability:

10000

Payment Type:

Money Gram, Western Union, D/P, L/C, T/T

Contact Now
Free Member

Contact Person Jason

858, East Lake, High-Tech Development Zone, Wuhan, Hubei

Contact Now

Product Specification

  • Purity (%): 99%
  • Brand Name: NEWBIO
  • Application: Pharmaceutical raw material

Product Description

Effective Anti Tumor Inhibitor API Tofacitinib Citrate
(CAS: **********9)


Chemical Information
Quick Details:
Product Name Tasocitinib
Molecular Formula C*6H*0N6O.C6H8O7
Molecular Weight **4.*9
Storage 3years in **0ºC
Targets Abl c-Src 
Dosage *0 nM; intraperitoneal injection
Target JAK3  JAK2 JAK1 ROCK2  LCK
IC*0 1 nM *0 nM **2 nM 3.4 μM 3.*7 μM
Product Name:  Tofacitinib Citrate
Other Names: *-PIPERIDINEPROPANENITRILE, *-METHYL**-(METHYL*7H-PYRROLO[2,*-D]PYRIMIDIN**-YLAMINO)-BETA-OXO-, (3R,4R)-, *-HYDROXY*1,2,*-PROPANETRICARBOXYLATE (1:1);*-Piperidinepropanenitrile, *-Methyl**-(Methyl*7H-pyrrolo[2,*-d]pyriMidin**-ylaMino)-β-oxo-, (3R,4R)-, *-hydroxy*1,2,*-propanetricarboxylate (1:1);Tofacitinib citrate (CP******0);Tofacitinib citrate;Tasocitinib citrate;Tasocitinib citric acid s...;Xeljanz;CP******0 (Tofacitinib citrate)Other Names:*-PIPERIDINEPROPANENITRILE, *-METHYL**-(METHYL*7H-PYRROLO[2,*-D]PYRIMIDIN**-YLAMINO)-BETA-OXO-, (3R,4R)-, *-HYDROXY*1,2,*-PROPANETRICARBOXYLATE (1:1);*-Piperidinepropanenitrile, *-Methyl**-(Methyl*7H-pyrrolo[2,*-d]pyriMidin**-ylaMino)-β-oxo-, (3R,4R)-, *-hydroxy*1,2,*-propanetricarboxylate (1:1);Tofacitinib citrate (CP******0);Tofacitinib citrate;Tasocitinib citrate;Tasocitinib citric acid s...;Xeljanz;CP******0 (Tofacitinib citrate)
CAS No.: **********9
MF:  C*6H*0N6O.C6H8O7
MW: **4.**7
Appearance: White or Nearly White Crystalline Powder
Purity:  *9%+
Specifications: Pharmaceutical Grade 
MOQ):  *0g
Packing:  Aluminium Foil Bag or as Required   
 
Product Description
Tofacitinib (formerly tasocitinib, CP******0) is a drug being investigated for the treatment of rheumatoid arthritis (RA), psoriasis, inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection. It is an inhibitor of the enzyme Janus kinase 3 (JAK3), which means that it interferes with the JAK-STAT signaling pathway that transmits information outside the cell into the cell nucleus, influencing DNA transcription. Recently it has been shown in a murine model of established arthritis, tofacitinib rapidly improved disease by inhibiting the production of inflammatory mediators and suppressing STAT*-dependent genes in joint tissue. This efficacy in this disease model correlated with the inhibition of both JAK1 and 3 signaling pathways, suggesting that tofacitinib may exert therapeutic benefit via pathways that are not exclusive to inhibition of JAK3.
 
Applications/Usage
A concentration of **0 nM. *0 nM, but not *0 nM, CP***0,**0 suppressed IFN- c production 4 days after Th1 differentiation conditions were established, while both *0 nM and *0 nM CP***0,**0 strongly suppressed IL*4 production under Th2 differentiation conditions. This suggests that CP***0,**0 inhibits both Th1 and Th2 differentiation, and that Th2 is more sensitive than Th1 to this drug. We then examined the effect of CP***0,**0 on Th*7 and induced T regulatory (iTreg) cells. CP***0,**0 enhanced IL**7 production while suppressing Foxp3 and IL**0 induction in a dose-dependent manner under Th*7 differentiation conditions. These data indicate that <**0 nM CP***0,**0 efficiently inhibits Th1, Th2 and iTreg while promoting Th*7, in vitro.
 
Tofacitinib citrate is currently approved for the treatment of rheumatoid arthritis.Tofacitinib citrate is an inhibitor of the enzyme janus kinase 3.

Country: China
Model No: -
FOB Price: 2.89 ~ 3.89 / Get Latest Price
Place of Origin: -
Price for Minimum Order: 2.89
Minimum Order Quantity: 100 Gram
Packaging Detail: Aluminum Foil Bags or Fiber Drum
Delivery Time: Within 7-12 days
Supplying Ability: 10000
Payment Type: Money Gram, Western Union, D/P, L/C, T/T
Product Group : Oncology API Raw Material

Related Products Wuhan Newbio Pharm-Tech Co., Ltd.

Send a direct inquiry to this supplier

To:

Jason < Wuhan Newbio Pharm-Tech Co., Ltd. >

I want to know: